1993
DOI: 10.1016/s0022-5223(19)34082-6
|View full text |Cite
|
Sign up to set email alerts
|

Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
43
2
1

Year Published

2001
2001
2013
2013

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 112 publications
(50 citation statements)
references
References 23 publications
4
43
2
1
Order By: Relevance
“…These include reduced NO production (7,12), reduced NO synthase activity (19), reduced NO release, and increased NO inactivation (27). Finally, increased sensitivity to or increased release of such as endothelium‐derived contracting factors (18,28) may theoretically also operate post CPB. Our data do not help to differentiate between the various mechanisms operating in this complex interaction.…”
Section: Discussionmentioning
confidence: 99%
“…These include reduced NO production (7,12), reduced NO synthase activity (19), reduced NO release, and increased NO inactivation (27). Finally, increased sensitivity to or increased release of such as endothelium‐derived contracting factors (18,28) may theoretically also operate post CPB. Our data do not help to differentiate between the various mechanisms operating in this complex interaction.…”
Section: Discussionmentioning
confidence: 99%
“…Platelet activation during and after cardiac surgery with CPB also exhibits large variation (66–69). Like PMNs, the platelets also lose shape, show pseudopods and upregulation of adhesion molecules upon activation (70).…”
Section: Inflammatory Events Within the Bloodmentioning
confidence: 99%
“…Increased endothelin levels have been found inconsistently in patients with PAH-CHD [86][87][88]. Increased endothelin levels have been correlated to a decreased pulmonary clearance after congenital heart surgery in patients with PAH-CHD [89][90][91]. In addition, to date there is still no meaningful evidence demonstrating receptor selectivity as clinically relevant [92].…”
Section: Endothelin-1 (Et-1) Receptor Antagonistsmentioning
confidence: 99%